Boston's InSpire MD Eyes $24.8 Million Series C Round Post author:Sam Post published:January 25, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Kalytera Therapeutics Announces Changes To Its Board Of Directors May 25, 2017 Biogen and AbbVie Voluntarily Pull Multiple Sclerosis Drug Off the Market March 1, 2018 Patient Death Forces Alnylam to Suspend Dosing in Hemophilia Trial, Stock Plunges September 6, 2017